BioSpace News Archive

A Settlement has been reached in a class action lawsuit, In re USC Student Health Center Litigation (No. 2:18-cv-04258-SVW), involving Dr. George M. Tyndall, a gynecologist at the University of Southern California (“USC”) Student Health Center from August 14, 1989 to June 21, 2016.

At the 61st American Association of Physicists in Medicine (AAPM) Annual Meeting & Exhibition, July 14 - 18 in San Antonio, Elekta (EKTA-B.ST) will feature advanced quality assurance (QA) and treatment planning solutions that simplify the delivery of radiation therapy techniques.

The First World Longevity Forum and Life Science Conference (WLF&LSC), organized by Hezhou Municipal People’s Government, opened on Friday in Hezhou city, south China’s Guangxi Zhuang Autonomous Region.

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today announced that its collaborator Janssen Biotech, Inc. (Janssen) has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration for the subcutaneous delivery of DARZALEX® (daratumumab) for patients with multiple myeloma.

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) seeking approval of a new subcutaneous (SC) formulation of DARZALEX® (daratumumab), an intravenous (IV) treatment approved for certain patients with multiple myeloma.

Dante Labs today introduced a new artificial intelligence (AI) tool to create personalized reports from whole genome sequencing data that leverages a person’s medical information to identify the most relevant insights across the six billion letters that make up human DNA.

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Ra Medical Systems, Inc. of the August 6, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

This month, the non-profit Medical Education Institute (MEI) celebrates 15 years of raising awareness and use of peritoneal dialysis and home hemodialysis through Home Dialysis Central, which launched on July 1, 2004.

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Heron Therapeutics, Inc. or the of the August 5, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

There is a growing preference for OTC drugs as they can be bought without a prescription.